Novartis Investigative Site

North York, Ontario M6B 3H7

2 studies enrolling now · 9 studies all time

What they study most

Alzheimer's Disease, Aortic Stenosis, Breast Cancer, Cardiovascular Events, Chronic Obstructive Pulmonary Disease, Coronary Artery Disease, Primary Prevention of Atherosclerotic Cardiovascular Disease, Uveitis

Studies at this site

• A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease — Recruiting now
• A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis — Recruiting now
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events — Running, not enrolling
• Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC — Completed
• Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis — Withdrawn before enrolling
• Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis — Stopped early
• A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People — Stopped early
• A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo — Completed